Drug Trial Radar · NCT05534165
Tecovirimat in Non-hospitalized Patients With Monkeypox
Last checked: Nov 19, 2026Latest source record: Mar 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Suspended
Enrollment
120
Planned (sponsor's estimate)
Start
Aug 14, 2023
Primary completion
Mar 13, 2025
Study completion Mar 31, 2026
Sponsor
- Lead sponsor
- Marina KleinAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- McGill University Health Centre/Research Institute of the McGill University Health Centre; University Health Network, Toronto; Unity Health Toronto; University of British Columbia; CIHR Canadian HIV Trials Network
- First posted
- Sep 9, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
PLATINUM-CAN is a parallel collaborative trial linked with the sister trial PLATINUM led by Oxford University. PLATINUM-CAN is a multi-centre, randomized, placebo-controlled trial of Tecovirimat in non-hospitalized patients with presumptive or PCR confirmed monkeypox infection. The study will provide evidence on the efficacy and safety of Tecovirimat for laboratory-confirmed monkeypox in outpatients with monkeypox infection and determine the feasibility of conducting interventional monkeypox trials in Canada.
Conditions
- Monkeypox
Interventions
TecovirimatDrug
600 mg po BID
PlaceboDrug
identical placebo 600 mg po BID
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to active lesion resolutionTime frame: Up to 28 days after randomization
- Feasibility and acceptability of conducting a pragmatic phase 3 interventional trial for outpatients with Monkeypox in CanadaTime frame: 4 months
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
St. Paul's Hospital, BC Centre for Excellence in HIV/AIDS
Vancouver, British Columbia, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
Toronto General Hospital
Toronto, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.